Amarin Corporation plc [AMRN] is -62.02% lower this YTD. Is it still time to buy?

Amarin Corporation plc [NASDAQ: AMRN] price plunged by -18.99 percent to reach at -$0.3. The company report on August 15, 2022 that Latest Research Evaluating VASCEPA®/VAZKEPA (icosapent ethyl) and Subgroups from the REDUCE-IT® Landmark Outcomes Trial to be Presented at the European Society of Cardiology (ESC) Congress.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded research on the effects of VASCEPA®/VAZKEPA (icosapent ethyl) in specific patient subgroups at increased risk of a cardiovascular (CV) event from the landmark REDUCE-IT® cardiovascular outcomes trial have been accepted for presentation at the European Society of Cardiology (ESC) Congress, both online and onsite in Barcelona, August 26-29, 2022.

The accepted abstracts include a Late-Breaking Science presentation on reduction of ST-segment Elevation MI with VASCEPA from the REDUCE-IT trial. These and other new findings will be presented by a variety of international academic collaborators based on research or analyses supported by Amarin.

A sum of 7973068 shares traded at recent session while its average daily volume was at 3.65M shares. Amarin Corporation plc shares reached a high of $1.545 and dropped to a low of $1.20 until finishing in the latest session at $1.28.

The one-year AMRN stock forecast points to a potential upside of 64.15. The average equity rating for AMRN stock is currently 3.00, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Amarin Corporation plc [AMRN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMRN shares is $3.57 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMRN stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

JP Morgan have made an estimate for Amarin Corporation plc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on May 06, 2022. While these analysts kept the previous recommendation, SVB Leerink raised their target price from $10 to $3. The new note on the price target was released on May 05, 2022, representing the official price target for Amarin Corporation plc stock. Previously, the target price had yet another drop from $10 to $3, while H.C. Wainwright kept a Neutral rating on AMRN stock.

The Average True Range (ATR) for Amarin Corporation plc is set at 0.13, with the Price to Sales ratio for AMRN stock in the period of the last 12 months amounting to 1.10. The Price to Book ratio for the last quarter was 0.88, with the Price to Cash per share for the same quarter was set at 0.77.

AMRN Stock Performance Analysis:

Amarin Corporation plc [AMRN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -23.35. With this latest performance, AMRN shares dropped by 0.00% in over the last four-week period, additionally sinking by -61.33% over the last 6 months – not to mention a drop of -76.25% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRN stock in for the last two-week period is set at 37.37, with the RSI for the last a single of trading hit 30.96, and the three-weeks RSI is set at 39.99 for Amarin Corporation plc [AMRN]. The present Moving Average for the last 50 days of trading for this stock 1.5386, while it was recorded at 1.5520 for the last single week of trading, and 2.6837 for the last 200 days.

Insight into Amarin Corporation plc Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Amarin Corporation plc [AMRN] shares currently have an operating margin of +4.15 and a Gross Margin at +78.71. Amarin Corporation plc’s Net Margin is presently recorded at +1.33.

Return on Equity for this stock inclined to 1.19, with Return on Assets sitting at 0.76.

Amarin Corporation plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 2.00.


The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMRN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Amarin Corporation plc go to 38.90%.

Amarin Corporation plc [AMRN] Insider Position Details

There are presently around $177 million, or 35.40% of AMRN stock, in the hands of institutional investors. The top three institutional holders of AMRN stocks are: SARISSA CAPITAL MANAGEMENT LP with ownership of 23,998,000, which is approximately -0.008% of the company’s market cap and around 0.30% of the total institutional ownership; BAKER BROS. ADVISORS LP, holding 21,169,805 shares of the stock with an approximate value of $27.1 million in AMRN stocks shares; and EVERSEPT PARTNERS, LP, currently with $17.0 million in AMRN stock with ownership of nearly 47.936% of the company’s market capitalization.

Positions in Amarin Corporation plc stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 90 institutional holders increased their position in Amarin Corporation plc [NASDAQ:AMRN] by around 22,924,583 shares. Additionally, 84 investors decreased positions by around 18,243,339 shares, while 90 investors held positions by with 96,952,770 shares. The mentioned changes placed institutional holdings at 138,120,692 shares, according to the latest SEC report filing. AMRN stock had 33 new institutional investments in for a total of 5,804,118 shares, while 33 institutional investors sold positions of 6,414,647 shares during the same period.


Please enter your comment!
Please enter your name here